Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Magia Diagnostics, a France-based viral infection testing spinout of University of Grenoble-Alpes in addition to research institutes CNRS, Inserm and Grenoble INP, has secured €1.3m ($1.5m) of equity funding from investors including regional tech transfer office Satt Linksium. The equity was raised alongside $1.9m of debt financing from government-owned investment bank Bpifrance and its partners. Health professional investor syndicates BH Invest and Magia Invest also supplied equity, as did medical device incubator Surgiqual Institute, Magia Diagnostics’ company founders and unnamed…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?